Efficacy of tofacitinib, an oral janus kinase inhibitor, on clinical signs of moderate-to-severe plaque psoriasis in different body regions (Q38435002)

From Wikidata
Jump to navigation Jump to search
scientific article published on March 2014
edit
Language Label Description Also known as
English
Efficacy of tofacitinib, an oral janus kinase inhibitor, on clinical signs of moderate-to-severe plaque psoriasis in different body regions
scientific article published on March 2014

    Statements

    Efficacy of tofacitinib, an oral janus kinase inhibitor, on clinical signs of moderate-to-severe plaque psoriasis in different body regions (English)
    Alan Menter
    Kim A Papp
    Huaming Tan
    Steve Tyring
    Marjorie Buonanno
    1 March 2014
    252-256

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit